
Thursday, March 16, 2017
Immortagen, a University of Iowa spinoff company, was started in 2014 to create individualized treatments for cancer patients. The company is still working on research and development. Read more online.
Immortagen, a University of Iowa spinoff company, was started in 2014 to create individualized treatments for cancer patients. The company is still working on research and development. Read more online.